Inspire Medical Systems (NASDAQ:INSP) CEO Timothy P. Herbert sold 10,000 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $70.00, for a total value of $700,000.00.
INSP opened at $62.68 on Friday. Inspire Medical Systems has a one year low of $35.43 and a one year high of $71.71. The stock’s fifty day moving average is $66.33 and its 200-day moving average is $58.97.
Inspire Medical Systems (NASDAQ:INSP) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.32) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.45) by $0.13. The firm had revenue of $18.03 million during the quarter, compared to the consensus estimate of $21.26 million. During the same period in the prior year, the firm posted ($0.43) EPS. The firm’s quarterly revenue was up 64.9% on a year-over-year basis.
A number of analysts have recently commented on the company. Bank of America reissued a “neutral” rating and issued a $75.00 price objective (up previously from $65.00) on shares of Inspire Medical Systems in a research note on Monday, July 8th. Zacks Investment Research raised Inspire Medical Systems from a “sell” rating to a “hold” rating in a research note on Saturday, August 3rd. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. Inspire Medical Systems currently has an average rating of “Hold” and a consensus target price of $57.20.
Institutional investors and hedge funds have recently bought and sold shares of the company. FinTrust Capital Advisors LLC bought a new stake in shares of Inspire Medical Systems in the 1st quarter worth $34,000. Marshall Wace North America L.P. bought a new stake in shares of Inspire Medical Systems in the 1st quarter worth $45,000. Royal Bank of Canada raised its stake in shares of Inspire Medical Systems by 593.3% in the 2nd quarter. Royal Bank of Canada now owns 1,040 shares of the company’s stock worth $63,000 after buying an additional 890 shares in the last quarter. Advisory Services Network LLC grew its holdings in shares of Inspire Medical Systems by 273.3% in the 1st quarter. Advisory Services Network LLC now owns 1,120 shares of the company’s stock worth $64,000 after acquiring an additional 820 shares during the last quarter. Finally, First Quadrant L P CA acquired a new position in shares of Inspire Medical Systems in the 2nd quarter worth $118,000.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Further Reading: What is the G-20?
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.